Journal of Pathology

Papers
(The H4-Index of Journal of Pathology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Information102
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance101
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy89
Escape from senescence: molecular basis and therapeutic ramifications87
Deep learning‐based H&E‐derived risk scores in colorectal cancer: associations with tumour morphology, biology, and predicted drug response78
Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients71
Roles of THBS2 + fibroblasts in malignant transformation of colorec65
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer63
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors63
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities62
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats51
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer†50
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation48
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment46
Tissue‐level heterogeneity in FECD : Descemet's membrane phenotypes and association with TCF4 46
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma45
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells42
40
Author Index40
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients40
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma40
CRISPR –Cas9 screening identifies the role of FER as a tumor suppressor38
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response38
36
Identification of actionable targets using DEPArray ‐based sorting of pure carcinoma and stromal populations from formalin‐fixed paraffin‐embedded ti35
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer34
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells34
Integrating computational pathology and proteomics to address tumor heterogeneity33
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer32
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT132
Pseudobudding: ruptured glands do not represent true tumor buds30
Field cancerization in breast cancer30
0.11107707023621